Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Canoll

Showing results (91-100 of 233) with videos related to

Pageof 24
Sort By:
Radiology|January 26, 2018
Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H MutationZachary K Englander, Craig I Horenstein, Stephen G Bowden, et al.
STAR Protocols|January 28, 2026
Protocol for the generation and xenotransplantation of human induced pluripotent stem cell-derived neural progenitor cells into the mouse forebrainJulie J McInvale, Chloe E Ayers, Hemanta Sarmah, et al.
Plos One|December 23, 2014
PARP inhibition restores extrinsic apoptotic sensitivity in glioblastomaGeorg Karpel-Massler, Fresia Pareja, Pascaline Aimé, et al.
Neuro-Oncology Practice|July 15, 2024
Biomarkers of immunotherapy in glioblastomaWilliam M Savage, Mitchell D Yeary, Anthony J Tang, et al.
Journal of Neurosurgery. Pediatrics|September 26, 2015
The use of fluorescein sodium in the biopsy and gross-total resection of a tectal plate gliomaTimothy H Ung, Christopher Kellner, Justin A Neira, et al.
Cells|February 9, 2024
EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase InhibitorLisa Sprinzen, Franklin Garcia, Angeliki Mela, et al.
Neurosurgery|May 1, 2009
The survival impact of postoperative infection in patients with glioblastoma multiformeLeif-Erik Bohman, Jade Gallardo, Todd C Hankinson, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumorsChia-Ing Jan, Shi-Wei Huang, Peter Canoll, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2016
Diversity and divergence of the glioma-infiltrating T-cell receptor repertoireJennifer S Sims, Boris Grinshpun, Yaping Feng, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 2014
Ribosome profiling reveals a cell-type-specific translational landscape in brain tumorsChristian Gonzalez, Jennifer S Sims, Nicholas Hornstein, et al.
Pageof 24

Showing results (91-100 of 233) with videos related to

Sort By:
Pageof 24
Radiology|January 26, 2018
Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H MutationZachary K Englander, Craig I Horenstein, Stephen G Bowden, et al.
STAR Protocols|January 28, 2026
Protocol for the generation and xenotransplantation of human induced pluripotent stem cell-derived neural progenitor cells into the mouse forebrainJulie J McInvale, Chloe E Ayers, Hemanta Sarmah, et al.
Plos One|December 23, 2014
PARP inhibition restores extrinsic apoptotic sensitivity in glioblastomaGeorg Karpel-Massler, Fresia Pareja, Pascaline Aimé, et al.
Neuro-Oncology Practice|July 15, 2024
Biomarkers of immunotherapy in glioblastomaWilliam M Savage, Mitchell D Yeary, Anthony J Tang, et al.
Journal of Neurosurgery. Pediatrics|September 26, 2015
The use of fluorescein sodium in the biopsy and gross-total resection of a tectal plate gliomaTimothy H Ung, Christopher Kellner, Justin A Neira, et al.
Cells|February 9, 2024
EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase InhibitorLisa Sprinzen, Franklin Garcia, Angeliki Mela, et al.
Neurosurgery|May 1, 2009
The survival impact of postoperative infection in patients with glioblastoma multiformeLeif-Erik Bohman, Jade Gallardo, Todd C Hankinson, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumorsChia-Ing Jan, Shi-Wei Huang, Peter Canoll, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2016
Diversity and divergence of the glioma-infiltrating T-cell receptor repertoireJennifer S Sims, Boris Grinshpun, Yaping Feng, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 2014
Ribosome profiling reveals a cell-type-specific translational landscape in brain tumorsChristian Gonzalez, Jennifer S Sims, Nicholas Hornstein, et al.
Pageof 24